Peptides show promise for early detection of pancreatic cancer
Pancreatic cancer is one of the cancers that remain the most lethal. But new research is producing an innovative technique for early detection of the first signs of pancreatic cancer. With an early diagnosis, medical interventions could be made to arrest the disease. The research is described in the Nano Research journal by Tony Hu, an associate professor of biomedical engineering in the Fulton Schools and his collaborators in a new field of research called peptidomics that is revealing important clues about effective cancer prognosis. The article was also posted on AZ BIO, the Arizona Bio Industry Association news site.